SPRB
Spruce Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$57.78
+0.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 18.21x
- P/E 2028E
- —
- P/S forward
- 1.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.98x
- Price / sales
- —
- Price / cash flow
- -3.90x
Enterprise value
- Enterprise value
- $77.4M
- EV / sales
- —
- EV / EBITDA
- -1.59x
- EV / EBIT
- -1.62x
- Market cap
- $166.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026